Warby Parker (WRBY) Revenue & Revenue Breakdown
Warby Parker Revenue Highlights
Latest Revenue (Y)
$871.90M
Latest Revenue (Q)
$242.45M
Main Segment (Y)
Eyewear Products
Warby Parker Revenue by Period
Warby Parker Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $871.90M | 13.04% |
| 2024-12-31 | $771.32M | 15.16% |
| 2023-12-31 | $669.76M | 11.98% |
| 2022-12-31 | $598.11M | 10.60% |
| 2021-12-31 | $540.80M | 37.36% |
| 2020-12-31 | $393.72M | 6.28% |
| 2019-12-31 | $370.46M | - |
Warby Parker generated $871.90M in revenue during NA 2025, up 13.04% compared to the previous quarter, and up 221.45% compared to the same period a year ago.
Warby Parker Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | $242.45M | 14.38% |
| 2025-12-31 | $211.97M | -4.38% |
| 2025-09-30 | $221.68M | 3.36% |
| 2025-06-30 | $214.47M | -4.16% |
| 2025-03-31 | $223.78M | 17.38% |
| 2024-12-31 | $190.64M | -0.94% |
| 2024-09-30 | $192.45M | 2.24% |
| 2024-06-30 | $188.22M | -5.89% |
| 2024-03-31 | $200.00M | 23.57% |
| 2023-12-31 | $161.85M | -4.71% |
| 2023-09-30 | $169.85M | 2.26% |
| 2023-06-30 | $166.09M | -3.42% |
| 2023-03-31 | $171.97M | 17.39% |
| 2022-12-31 | $146.49M | -1.54% |
| 2022-09-30 | $148.78M | -0.57% |
| 2022-06-30 | $149.62M | -2.35% |
| 2022-03-31 | $153.22M | 15.30% |
| 2021-12-31 | $132.89M | -3.26% |
| 2021-09-30 | $137.37M | 4.42% |
| 2021-06-30 | $131.56M | -5.33% |
| 2021-03-31 | $138.97M | 23.16% |
| 2020-12-31 | $112.84M | 8.40% |
| 2020-09-30 | $104.09M | 17.76% |
| 2020-06-30 | $88.39M | - |
| 2020-03-31 | $88.39M | - |
Warby Parker generated $242.45M in revenue during Q1 2026, up 14.38% compared to the previous quarter, and up 127.17% compared to the same period a year ago.
Warby Parker Revenue Breakdown
Warby Parker Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|
| Services And Other | $55.69M | $40.51M | $29.38M | $17.84M |
| Eyewear Products | $719.06M | $730.80M | $568.73M | $522.96M |
Latest
Warby Parker's latest annual revenue breakdown by segment (product or service), as of Dec 25: Eyewear Products (92.81%), and Services And Other (7.19%).
Quarterly Revenue by Product
| Product/Service | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eyewear Products | $201.44M | $99.49M | $207.22M | $201.50M | $210.84M | $367.57M | $175.62M | $187.62M | $159.80M | $156.68M | $162.35M | $137.61M | $140.82M | $142.99M | $147.32M | $127.63M | $133.04M |
| Services And Other | - | $15.32M | $14.46M | $12.97M | $12.94M | $11.30M | $16.83M | $12.38M | $10.05M | $9.41M | $9.62M | $8.88M | $7.96M | $6.64M | $5.90M | $5.26M | $4.34M |
Latest
Warby Parker's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Eyewear Products (100.00%).
Warby Parker Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BHC | Bausch Health Companies | $10.16B | $912.00M |
| XRAY | DENTSPLY SIRONA | $3.68B | $880.00M |
| QDEL | QuidelOrtho | $2.73B | $699.90M |
| ICUI | ICU Medical | $2.23B | $530.23M |
| CON | Concentra Group Parent | $2.16B | $569.55M |
| ITGR | Integer | $1.85B | $439.58M |
| HAE | Haemonetics | $1.36B | $338.97M |
| WRBY | Warby Parker | $871.90M | $242.45M |
| LMAT | LeMaitre Vascular | $249.60M | $61.05M |
| BEAM | Beam Therapeutics | - | - |